(0.25%) 5 112.55 points
(0.21%) 38 319 points
(0.28%) 15 973 points
(-1.00%) $83.01
(4.84%) $2.02
(0.07%) $2 348.90
(0.24%) $27.60
(4.04%) $959.35
(-0.18%) $0.933
(-0.28%) $10.99
(-0.48%) $0.797
(1.73%) $93.46
3.12% € 42.95
Live Chart Being Loaded With Signals
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally...
Stats | |
---|---|
Tagesvolumen | 13 855.00 |
Durchschnittsvolumen | 8 710.00 |
Marktkapitalisierung | 522.10M |
EPS | €0 ( 2024-03-28 ) |
Nächstes Ertragsdatum | ( €0 ) 2024-06-07 |
Last Dividend | €0.970 ( 2023-05-18 ) |
Next Dividend | €0 ( N/A ) |
P/E | 40.14 |
ATR14 | €0.168 (0.39%) |
Volumen Korrelation
Stratec SE Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Stratec SE Korrelation - Währung/Rohstoff
Stratec SE Finanzdaten
Annual | 2023 |
Umsatz: | €261.91M |
Bruttogewinn: | €64.85M (24.76 %) |
EPS: | €1.080 |
FY | 2023 |
Umsatz: | €261.91M |
Bruttogewinn: | €64.85M (24.76 %) |
EPS: | €1.080 |
FY | 2022 |
Umsatz: | €274.63M |
Bruttogewinn: | €79.49M (28.94 %) |
EPS: | €2.41 |
FY | 2021 |
Umsatz: | €287.34M |
Bruttogewinn: | €87.71M (30.53 %) |
EPS: | €3.30 |
Financial Reports:
No articles found.
Stratec SE Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0.970 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.0267 | 2004-05-17 |
Last Dividend | €0.970 | 2023-05-18 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | €11.02 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.94 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.98 | |
Div. Directional Score | 7.45 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PRU.DE | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
BEZ.DE | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
IBM.DE | Ex Dividend Knight | 2023-08-09 | Quarterly | 0 | 0.00% | |
SNW.DE | Ex Dividend Knight | 2023-05-30 | Annually | 0 | 0.00% | |
CPIA.F | No Dividend Player | 2023-06-29 | Annually | 0 | 0.00% | |
LHOG.F | Ex Dividend Junior | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
185.DE | Ex Dividend Junior | 2023-08-07 | Quarterly | 0 | 0.00% | |
UTDI.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
ED4.DE | Ex Dividend Junior | 2023-06-29 | Sporadic | 0 | 0.00% | |
NOA3.DE | Ex Dividend Knight | 2023-10-23 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0499 | 1.500 | 9.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0272 | 1.200 | 9.09 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0573 | 1.500 | -0.474 | -0.711 | [0.1 - 1] |
payoutRatioTTM | 0.0000765 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.54 | 0.800 | 2.28 | 1.823 | [1 - 3] |
quickRatioTTM | 1.044 | 0.800 | 8.57 | 6.85 | [0.8 - 2.5] |
cashRatioTTM | 0.348 | 1.500 | 9.18 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.267 | -1.500 | 5.56 | -8.34 | [0 - 0.6] |
interestCoverageTTM | 5.82 | 1.000 | 8.95 | 8.95 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.598 | 2.00 | 9.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.165 | 2.00 | 9.92 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.548 | -1.500 | 7.81 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.248 | 1.000 | 9.21 | 9.21 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0887 | 1.000 | -0.225 | -0.225 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.152 | 1.000 | -0.267 | -0.267 | [0.2 - 2] |
assetTurnoverTTM | 0.546 | 0.800 | 9.69 | 7.75 | [0.5 - 2] |
Total Score | 10.92 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.75 | 1.000 | 6.19 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0573 | 2.50 | -0.305 | -0.711 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.165 | 2.00 | 9.95 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.33 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.598 | 2.00 | 9.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0000765 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0742 | 1.000 | -0.646 | 0 | [0.1 - 0.5] |
Total Score | 3.98 |
Stratec SE
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.